Pay in 4 interest-free payments of $6.97 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
503B Classification Clinical evidence emphasizes that the regulatory classification of a compounding pharmacy503A (traditional compounding) versus 503B (outsourcing facilities)significantly impacts product quality assurance, sterility testing, and oversight mechanisms
This formulation is ready to draw and inject, with no reconstitution required
This is not unique to Belmar
Retrieved from [Link to official prescribing information, e.g., Novo Nordisk website or FDA database] [2] U.S
%25201.png)
It is sold under the brand name Ozempic and is produced by the pharmaceutical company Novo Nordisk
US$ 21.12
US$ 21.50
US$ 24.59
US$ 21.92
US$ 24.52
US$ 20.93
